LBRX
Price:
$19.25
Market Cap:
$487.01M
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.
Industry
Biotechnology
IPO Date
2025-09-11
Stock Exchange
NASDAQ
Ticker
LBRX
According to LB Pharmaceuticals Inc Common Stock’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of LB Pharmaceuticals Inc Common Stock over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), LBRX's Dividend Yield was at its highest in in the March 2024 quarter at 0%. The Dividend Yield was at its lowest in in the March 2024 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of LB Pharmaceuticals Inc Common Stock Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
The current Dividend Yield of LB Pharmaceuticals Inc Common Stock (LBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
LB Pharmaceuticals Inc Common Stock’s Dividend Yield is less than Rocket Pharmaceuticals, Inc. (0%), less than Aura Biosciences, Inc. (0%), less than Annexon, Inc. (0%), less than Solid Biosciences Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Altimmune, Inc. (0%), less than Autolus Therapeutics plc (0%), less than DBV Technologies S.A. (0%), less than Design Therapeutics, Inc. (0%), less than Korro Bio, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $370.12M | |
| 0% | $409.59M | |
| 0% | $536.98M | |
| 0% | $461.22M | |
| 0% | $314.97M | |
| 0% | $468.65M | |
| 0% | $417.84M | |
| 0% | $312.18M | |
| 0% | $559.35M | |
| 0% | $63.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LB Pharmaceuticals Inc Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LB Pharmaceuticals Inc Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is LB Pharmaceuticals Inc Common Stock's Dividend Yield?
How is the Dividend Yield calculated for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the highest Dividend Yield for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the 3-year average Dividend Yield for LB Pharmaceuticals Inc Common Stock (LBRX)?
What is the 5-year average Dividend Yield for LB Pharmaceuticals Inc Common Stock (LBRX)?
How does the current Dividend Yield for LB Pharmaceuticals Inc Common Stock (LBRX) compare to its historical average?